Comparative statistics by cancer registry
Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
(Kampala, Uganda, 1993-1997 cases followed-up until 1999)Click on cancer site (ICD-10 code) for comparison
| Site | ICD-10 | No. of cases included | Complete FU | Incomplete FU: loss to FU | % with Complete FU at 5 years | Median FU (in months) | ||||||
| Alive/dead | At end of FU | No. | % | % lost to FU: years from diagnosis | ||||||||
| No. | % | <1 | 1-3 | 3-5 | >5 | |||||||
| C11 | Nasopharynx | 49 | 31 | 63.3 | 18 | 36.7 | 32.7 | 4.1 | 0.0 | 0.0 | 63.3 | 6.3 |
| C15 | Oesophagus | 180 | 152 | 84.4 | 28 | 15.6 | 12.8 | 2.8 | 0.0 | 0.0 | 84.4 | 7.2 |
| C16 | Stomach | 90 | 67 | 74.4 | 23 | 25.6 | 21.1 | 4.4 | 0.0 | 0.0 | 74.4 | 4.2 |
| C18 | Colon | 51 | 41 | 80.4 | 10 | 19.6 | 19.6 | 0.0 | 0.0 | 0.0 | 80.4 | 6.6 |
| C19-20 | Rectum | 50 | 40 | 80.0 | 10 | 20.0 | 18.0 | 2.0 | 0.0 | 0.0 | 80.0 | 9.4 |
| C22 | Liver | 116 | 101 | 87.1 | 15 | 12.9 | 12.1 | 0.0 | 0.9 | 0.0 | 87.1 | 5.9 |
| C33-34 | Lung | 47 | 41 | 87.2 | 6 | 12.8 | 12.8 | 0.0 | 0.0 | 0.0 | 87.2 | 4.8 |
| C46 | Kaposi sarcoma | 370 | 248 | 67.0 | 122 | 33.0 | 21.6 | 9.2 | 1.9 | 0.3 | 67.3 | 8.1 |
| C50 | Breast | 162 | 96 | 59.3 | 66 | 40.7 | 27.8 | 9.3 | 1.9 | 1.9 | 61.1 | 10.9 |
| C53 | Cervix | 283 | 149 | 52.7 | 134 | 47.3 | 35.0 | 11.3 | 0.7 | 0.4 | 53.0 | 8.3 |
| C56 | Ovary | 66 | 48 | 72.7 | 18 | 27.3 | 15.2 | 7.6 | 3.0 | 1.5 | 74.2 | 5.0 |
| C61 | Prostate | 154 | 119 | 77.3 | 35 | 22.7 | 16.2 | 3.9 | 2.6 | 0.0 | 77.3 | 26.2 |
| C69 | Eye | 81 | 38 | 46.9 | 43 | 53.1 | 37.0 | 14.8 | 1.2 | 0.0 | 46.9 | 14.9 |
| C73 | Thyroid | 39 | 22 | 56.4 | 17 | 43.6 | 25.6 | 15.4 | 0.0 | 2.6 | 59.0 | 7.5 |
| C82-85+C96 | Non-Hodgkin lymphoma | 178 | 118 | 66.3 | 60 | 33.7 | 23.0 | 7.9 | 1.7 | 1.1 | 67.4 | 9.4 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |